Back to News
Market Impact: 0.22

Assa Abloy shares up as RBC eyes M&A bounty, 20% upside ahead of FY26

Analyst EstimatesAnalyst InsightsCompany FundamentalsCorporate Guidance & OutlookM&A & Restructuring
Assa Abloy shares up as RBC eyes M&A bounty, 20% upside ahead of FY26

RBC initiated Assa Abloy at "outperform" with a SEK400 price target, implying about 20% upside from SEK338.10, and said even without multiple re-rating it sees roughly 11% annual total shareholder return. The broker highlighted strong free cash flow, a 10% CAGR since 2005, and M&A-driven value creation, while forecasting 2026 revenue of SEK156.99 billion and adjusted EPS of SEK15.51. Shares rose nearly 2% on the call.

Analysis

The key second-order takeaway is that Assa’s rerating is less about near-term cyclicals and more about investors paying up for a self-funded roll-up machine with unusually durable cash conversion. If management keeps M&A discipline intact, the market can tolerate slower organic growth because accretion from multiple arbitrage and synergies effectively lowers the hurdle rate on every deal; that makes the equity behave more like a compounder than a traditional industrial. The current discount to the sector looks inconsistent with that quality profile, especially if margin expansion continues as North America becomes a bigger share of mix.

The main underappreciated risk is that the market may be extrapolating past M&A success into a tougher capital-allocation regime. Once a serial acquirer gets larger, the pool of 2x sales targets shrinks, integration complexity rises, and the probability of overpaying increases just as the valuation anchor has already tightened. If European construction weakens and multiple compression hits the whole industrial complex, Assa could de-rate even while fundamentals remain solid, because the stock’s relative valuation is now the primary support.

The near-term catalyst path is simple: any confirmation of margin progression or deal cadence should keep the multiple bid over the next 3-6 months. The contrarian view is that the stock may already be pricing in an unusually clean M&A run-rate and a benign macro backdrop; if either slips, the downside is more about multiple compression than earnings revision. This is a quality compounder, but the setup is no longer cheap on an absolute basis, so the risk/reward is better expressed versus cyclicals than as an outright chase.